Log in to save to my catalogue

Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review o...

Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4951cfff9df4cedae8ef0155d68cb57

Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses

About this item

Full title

Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses

Publisher

Cheshire: Springer Healthcare

Journal title

Dermatology and therapy, 2024-10, Vol.14 (10), p.2709-2726

Language

English

Formats

Publication information

Publisher

Cheshire: Springer Healthcare

More information

Scope and Contents

Contents

Factors such as obesity, alcohol consumption, and tobacco use are associated with both increased psoriasis severity and inadequate response to systemic and biologic therapies. Obesity is linked to chronic inflammation, which can contribute to psoriasis pathogenesis. Fixed-dose therapies may have reduced efficacy in patients with a higher body mass...

Alternative Titles

Full title

Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a4951cfff9df4cedae8ef0155d68cb57

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4951cfff9df4cedae8ef0155d68cb57

Other Identifiers

ISSN

2193-8210

E-ISSN

2190-9172

DOI

10.1007/s13555-024-01264-3

How to access this item